Skip to Main Content

Paper Details

Resistance mechanisms to TP53-MDM2 inhibition identified by in vivo piggyBac transposon mutagenesis screen in an Arf<sup>-/-</sup> mouse model.
Proc Natl Acad Sci U S A
44
2017
87 genes, Arf, Arf-/-, B-cell lymphoma-extra large, BCL-xL, Bcl-xL, CDKN2A, HDM201, MDM2, MDM2 protein, MDM4, Mdm4, NTrp63, NTrp73, PB, PB transposon, TP53, TP53 dominant negative truncations, TP53 family members, TP53 gene, TP53 protein, TP53 wild, TP53 wild-type tumors, Trp53, Tumors, allograft models, cancer, double minute 2 protein, human, mice, mouse, p14ARF, p53 wild, p53 wild-type cell lines, patient, resistant subclones, spontaneous tumors, transformation-related protein 53, tumor, tumor protein 53, tumors
Author NameAffiliation
Joseph LehárNovartis Institutes for BioMedical Research
Stephane FerrettiNovartis Institutes for BioMedical Research
William R SellersNovartis Institutes for BioMedical Research
  • 1 - 3

Datasets